Jay R. Luly
2013
In 2013, Jay R. Luly earned a total compensation of $1.6M as President and Chief Executive Officer at Enanta Pharmaceuticals, a 114% increase compared to previous year.
Compensation breakdown
Bonus | $235,422 |
---|---|
Option Awards | $960,468 |
Salary | $448,512 |
Other | $4,439 |
Total | $1,648,841 |
Luly received $960.5K in option awards, accounting for 58% of the total pay in 2013.
Luly also received $235.4K in bonus, $448.5K in salary and $4.4K in other compensation.
Rankings
In 2013, Jay R. Luly's compensation ranked 4,568th out of 12,286 executives tracked by ExecPay. In other words, Luly earned more than 62.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,568 | 63rd |
Manufacturing | 1,562 | 66th |
Chemicals And Allied Products | 450 | 69th |
Drugs | 313 | 73rd |
Pharmaceutical Preparations | 251 | 72nd |
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2013.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019